TRAVERE THERAPEUTICS INC's ticker is and the CUSIP is 89422GAA5. A total of 26 filers reported holding TRAVERE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,301,872 | +4641.2% | 479,520 | -17.8% | 0.01% | – |
| Q2 2023 | $90,733 | -99.4% | 583,494 | -8.2% | 0.00% | -100.0% |
| Q1 2023 | $14,280,654 | +11070174.4% | 635,543 | +3.3% | 0.04% | +4400.0% |
| Q4 2022 | $129 | -99.9% | 615,276 | +13.7% | 0.00% | 0.0% |
| Q3 2022 | $134,000 | -38.5% | 541,358 | -37.8% | 0.00% | – |
| Q2 2022 | $218,000 | – | 870,064 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Context Capital Management, LLC | 18,167 | $17,858 | 1.50% |
| BRAIDWELL LP | 28,350,000 | $27,868,050 | 0.92% |
| READYSTATE ASSET MANAGEMENT LP | 9,000,000 | $8,847,000 | 0.82% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 21,382,000 | $20,985 | 0.77% |
| UBS OCONNOR LLC | 20,000,000 | $19,700,500 | 0.60% |
| CSS LLC/IL | 8,178,000 | $8,038,680 | 0.53% |
| WOLVERINE ASSET MANAGEMENT LLC | 37,900,000 | $37,317,810 | 0.44% |
| Segantii Capital Management Ltd | 10,000,000 | $9,827,050 | 0.34% |
| LINDEN ADVISORS LP | 28,993,000 | $28,511,354 | 0.30% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 30,893,000 | $30,367,819 | 0.15% |